![Foto de ARIADNA](/img/nophoto.png)
ARIADNA
BARGIELA SCHONBRUNN
INVEST DOCT UV SENIOR
Publicaciones (19) Publicaciones de ARIADNA BARGIELA SCHONBRUNN
2024
-
Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models
Biological Research, Vol. 57, Núm. 1
2023
-
CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2
Molecular Therapy - Nucleic Acids, Vol. 31, pp. 324-338
-
Neuroprotective properties of queen bee acid by autophagy induction
Cell Biology and Toxicology, Vol. 39, Núm. 3, pp. 751-770
-
Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice
Scientific Reports, Vol. 13, Núm. 1
2022
-
Development of potent tripodal G-quadruplex DNA binders and their efficient delivery to cancer cells by aptamer functionalised liposomes
Organic and Biomolecular Chemistry, Vol. 21, Núm. 5, pp. 1000-1007
-
Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis
Frontiers in Cell and Developmental Biology
2021
-
Defined d-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease
Scientific Reports, Vol. 11, Núm. 1
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model
FASEB Journal, Vol. 35, Núm. 10
-
Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
Molecular Therapy - Nucleic Acids, Vol. 25, pp. 652-667
-
Practicing logical reasoning through Drosophila segmentation gene mutants
Biochemistry and Molecular Biology Education, Vol. 49, Núm. 5, pp. 729-736
-
The hallmarks of myotonic dystrophy type 1 muscle dysfunction
Biological Reviews, Vol. 96, Núm. 2, pp. 716-730
2020
-
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
Molecular Therapy - Nucleic Acids, Vol. 19, pp. 278-292
2019
-
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 50, pp. 25203-25213
2016
-
Six serum miRNAs fail to validate as myotonic dystrophy type 1 biomarkers
PLoS ONE, Vol. 11, Núm. 2
2015
-
Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
DMM Disease Models and Mechanisms, Vol. 8, Núm. 7, pp. 679-690
2014
2013
-
Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model
DMM Disease Models and Mechanisms, Vol. 6, Núm. 1, pp. 184-196
2010
-
A GFP-tagged muscleblind C protein isoform reporter construct
Fly, Vol. 4, Núm. 4